Mediaboss Marketing

About Proactive

Proactive leads the world in up-to-the-minute, multi-media news provision, events organisation, investorrelations management and investor research Read more

Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced independently by our experienced and qualified teams of news journalists.

Proactive news team spans the worlds key finance and investing hubs with bureaus and studios in London, New York, Toronto, Vancouver, Sydney and Perth.

We are experts in medium and small-cap markets, we also keep our community up to date with blue-chip companies, commodities and broader investment stories. This is content that excites and engages motivated private investors.

The team delivers news and unique insights across the market including but not confined to: biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto and emerging digital and EV technologies.

Proactive has always been a forward looking and enthusiastic technology adopter.

Our human content creators are equipped with many decades of valuable expertise and experience. The team also has access to and use technologies to assist and enhance workflows.

Proactive will on occasion use automation and software tools, including generative AI. Nevertheless, all content published by Proactive is edited and authored by humans, in line with best practice in regard to content production and search engine optimisation.

Excerpt from:
Team Internet Group looks to AI initiatives to drive digital marketing ... - Proactive Investors UK

New York, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Medical Thing (IoMT) Market: Trends, Opportunities and Competitive Analysis [2023-2028]" - https://www.reportlinker.com/p06489144/?utm_source=GNW

Internet of Medical Thing Market Trends and Forecast The future of the global internet of medical thing (IoMT) market looks promising with opportunities in the hospital & clinic, home care, and research institute markets. The global internet of medical thing market is expected to reach an estimated $140.7 billion by 2028 with a CAGR of 24% from 2023 to 2028. The major drivers for this market are emergence of 5G technology, growing adoption of connected devices in the healthcare sector, and increasing adoption of smart wearable gadgets for efficient patient monitoring and asset management.

Internet of Medical Thing Market

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown here.

Internet of Medical Thing Market by Segments

Internet of Medical Thing Market by Segment

The study includes trends and forecast for the global internet of medical thing market by product type, application, end use, and region, as follows:

Internet of Medical Thing Market by Product Type [Shipment Analysis by Value from 2017 to 2028]: Smart Wearables Point of Care Kits Home Use Devices

Internet of Medical Thing Market by Application [Shipment Analysis by Value from 2017 to 2028]: Telemedicine Patient Monitoring Medication Management Others

Internet of Medical Thing Market by End Use [Shipment Analysis by Value from 2017 to 2028]: Hospitals & Clinics Home Care Research Institutes

Internet of Medical Thing Market by Region [Shipment Analysis by Value from 2017 to 2028]: North America Europe Asia Pacific The Rest of the World List of Internet of Medical Thing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, internet of medical thing companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the internet of medical thing companies profiled in this report include: GE healthcare Koninklijke Philips Medtronic MiniMed LifeFuels Meru Health Breathometer Carre Technologies Internet of Medical Thing Market Insights The analyst forecasts that telemedicine will remain the largest segment over the forecast period due to the expanding use of this technology to enable real-time data sharing and efficient communication in the healthcare industry. Hospitals & clinics will remain the largest segment due to increasing cases of chronic diseases, growing demand for regular health check -ups among patients, and rising acceptance of modern technology in healthcare facilities to monitor patients health conditions. North America will remain the largest region over the forecast period due to rising preference for self-health management among patients, presence of well-established healthcare infrastructure, and presence of key players in the region. Features of the Internet of Medical Thing Market

Market Size Estimates: Internet of medical thing market size estimation in terms of value ($B) Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions. Segmentation Analysis: Internet of medical thing market size by various segments, such as by product type, application, end use, and region Regional Analysis: Internet of medical thing market breakdown by North America, Europe, Asia Pacific, and the Rest of the World. Growth Opportunities: Analysis on growth opportunities in different by product type, application, end use, and regions for the internet of medical thing market. Strategic Analysis: This includes M&A, new product development, and competitive landscape for the internet of medical thing market. Analysis of competitive intensity of the industry based on Porters Five Forces model. FAQ Q1. What is the internet of medical thing market size? Answer: The global internet of medical thing market is expected to reach an estimated $140.7 billion by 2028. Q2. What is the growth forecast for internet of medical thing market? Answer: The global internet of medical thing market is expected to grow with a CAGR of 24% from 2023 to 2028. Q3. What are the major drivers influencing the growth of the internet of medical thing market? Answer: The major drivers for this market are emergence of 5G technology, growing adoption of connected devices in the healthcare sector, and increasing adoption of smart wearable gadgets for efficient patient monitoring and asset management. Q4. What are the major segments for internet of medical thing market? Answer: The future of the global internet of medical thing (IoMT) market looks promising with opportunities in the hospital & clinic, home care, and research institute markets. Q5. Who are the key internet of medical thing companies?

Answer: Some of the key internet of medical thing companies are as follows: GE healthcare Koninklijke Philips Medtronic MiniMed LifeFuels Meru Health Breathometer Carre Technologies Q6. Which internet of medical thing segment will be the largest in future? Answer:The analyst forecasts that telemedicine will remain the largest segment over the forecast period due to the expanding use of this technology to enable real-time data sharing and efficient communication in the healthcare industry. Q7. In internet of medical thing market, which region is expected to be the largest in next 5 years? Answer: North America will remain the largest region over the forecast period due to rising preference for self-health management among patients, presence of well-established healthcare infrastructure, and presence of key players in the region. Q8. Do we receive customization in this report? Answer: Yes, The analyst provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions Q.1. What are some of the most promising, high-growth opportunities for the global internet of medical thing market by product type (smart wearables, point of care kits, and home use devices), application (telemedicine, patient monitoring, medication management, and others), end use (hospitals & clinics, home care, and research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)? Q.2. Which segments will grow at a faster pace and why? Q.3. Which region will grow at a faster pace and why? Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market? Q.5. What are the business risks and competitive threats in this market? Q.6. What are the emerging trends in this market and the reasons behind them? Q.7. What are some of the changing demands of customers in the market? Q.8. What are the new developments in the market? Which companies are leading these developments? Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth? Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution? Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

For any questions related to medical thing (IoMT)market or related to medical thing (IoMT)companies, medical thing (IoMT)market size, medical thing (IoMT)market share, medical thing (IoMT) analysis,write Lucintel analyst at email: helpdesk@lucintel.com we will be glad to get back to you soon. Read the full report: https://www.reportlinker.com/p06489144/?utm_source=GNW

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

More:
The global internet of medical thing market is expected to reach an ... - GlobeNewswire

Jawan fever has been gripping the nation with the Shah Rukh Khan and Nayanthara starrer poised to make a big splash at the box office. Cashing in on the films buzz and the SRK mania are brands that want to ride the Jawan wave through integration, which has always been an effective tool to leave a mark on the minds of moviegoers.

Zomato, Bondtite, Sandisk, Asian Paints, Astral Pipes, and Just in Time watches are some of the brands that have collaborated with the film, banking heavily on Jawans promise. These brands can be spotted in the films trailer itself: the Asian Paints billboard, Sanya Malhotra in the red Zomato delivery person uniform, and the SanDisk and Bondtite branding inside a metro are some that can be spotted easily.

In an attempt to keep up with the AI trend, SRK also collaborated with Aaj Tak's bot anchor. During a conversation with SRK, Sana the first AI Anchor in India, posted on social media, "Aap ka charm dekh kar Mere AI dil mein bhi kuch kuch hota hai."

Jawan is a highly anticipated film with a pan-India appeal starring superstars from the North and the South of India. According to Eral Diet Report, the film may see a blockbuster opening of Rs 60 crore on the first day alone and a lifetime net box office in the range of Rs 350 crore to Rs 450 crore.

Jawan may breach the upper end of its guidance if the content is good and finds relevance with the audience. This film is set to have a strong recall in southern markets too, as it is directed by Atlee. Expect collections from the dubbed version to be ~10% of the overall net BO for Jawan, said the report.

The last SRK superhit Pathaan didnt see many brands ride the integration bandwagon, but Jawan is a different story. And it may have something to do with Khans brand value going up post-Pathaan.

Says Nisha Sampath, Brand Consultant, and Founder, of Bright Angles Consulting, "The power of Brand SRK has never really been in doubt, though he was temporarily mired in controversy. I would say that Pathaan served as a reminder and reinforcement of his star power and appeal in mass India, which led to brands being even more keen to re-engage with him. Its a bit like Dhoni captaining CSK to yet another trophy his appeal is evergreen, but the victory created a huge surge of love and craze for Brand Dhoni. And all marketers want to ride on it."

Samit Sinha, Founder & Managing Partner, Alchemist Brand Consulting, said, When a brand decides to associate with an upcoming film, it is always a gamble, albeit a calculated gamble. There is no guarantee in advance of a films box office success. Clearly, the enormous success of Pathaan created a strong anticipatory buzz aroundJawan, and many believe that it will replicate the success of Pathaan. It is also indicative of Shah Rukh Khans return to ascendancy and his seemingly unabated star appeal. Yes, brand SRK is resurgent and it also shows that his iconic status in Indian cinema is not a fluke.

Speaking about the promising partnership with Jawan, Kairav Engineer, Executive Director at Astral Limited, shared his enthusiasm, stating, "We are delighted to team up with 'Jawan,' a movie that resonates with our values of determination and unity. We eagerly anticipate the release of the movie on 7th September and the impact of our shared message."

The promise of a good ROI is what draws brands to such collaborations, says Lloyd Mathias, Business Strategist and Independent Director. Associating with a film or executing such collaborations, gives a positive spin, which converts into a better ROI, he states.

The caveat, however, is making the collaboration seem authentic and organic instead of being force fit. Sampath points out: When the lyrics Zandu Balm Hui were used in the song Munni Badnaam Hui it came from pure creative inspiration, without the intervention of the brand and it created a viral magic. Collaborations between brand and movie teams should be inspired, should allow for creativity and push for serendipity. This requires that brand teams should stop trying to force fit agendas, and seek harder to find brands where they fit best versus just opting for the biggest star names.

Read more news about (marketing news, latest marketing news,internet marketing, marketing India, digital marketing India, media marketing India, advertising news)

See the original post:
How SRK's Jawan is winning the brand integration 'jung' - Exchange4Media

Biopharmaceutical marketing has undergone a dramatic transformation in the past few years. In the 1990s, marketing was primarily salesforce-driven and healthcare provider (HCP)-focused, but by the 2020s, the biopharma salesforce size had shrunk dramatically and access to HCPs was becoming more difficult.1

Then the COVID-19 pandemic turned the world of biopharma marketing upside down. Sales rep access to HCPs had already been in decline; then, sales rep office and hospital visits were practically eliminated. Sales reps began replacing in-person sales meetings with more digital and virtual deliverables to stay engaged with HCPs.2 HCPs responding to a survey of more than 1,300 M.D.s reported that more than 95% of all contact with sales reps took place via virtual channels; more than 75% of physicians said they wanted to either maintain or increase this shift, irrespective of vaccine status, suggesting that digital marketing is here to stay.3

Traditionally, biopharma has been slow to incorporate innovative digital technologies for marketing, but as the pandemic began, there was a sudden increase in digital marketing investments.4 Many biopharma companies have begun significantly increasing digital marketing. In 2020, biopharma spent an estimated $9.53 billion on digital marketing, up 14.2% from 2019.1, 5

This article examines what can provide results in this new realm of digital marketing. We will also look at how to engage healthcare providers using digital channels, by providing information they will value.

Marketers have limited visibility into what is and is not working in the new digital marketing landscape.6 Research shows that only half of pharma and biopharma respondents use quantitative metrics to determine the long-term impact of their marketing efforts. As a result, few biopharma marketers clearly understand which of their efforts are most productive. Research also shows that marketers typically waste about 26% of their budgets on channels and strategies that are ineffective.1, 6, 7

This means that although biopharma companies rely increasingly on digital marketing, they may be missing the opportunity to engage their markets with more relevant, targeted interactions. Biopharma companies typically market products to broad audiences using a wide spectrum of channels, such as TV, the internet and sales representatives, but this omnichannel approach often results in messaging that is disconnected and episodic.6 HCPs are already overwhelmed, making it critical to leverage analytics and data to understand the right content, right channel and right timing for messaging to be effective.3, 8

For instance, HCPs are difficult to reach using traditional Internet marketing. According to a recent report, many physicians today spend fewer than 10 nonworking hours online a week compared to the average U.S. Internet user, who spends almost 7 hours online daily.9

In contrast, physicians spend an average of 4.5 hours a day interacting with their electronic health records (EHRs). On average, they spend 16 minutes on their EHRs per patient encounter. If the average HCP sees 20 patients a day, that means they spend about 320 minutes (about five-and-a-half hours) daily in their EHR systems.9, 10 This provides a massive opportunity for pharma companies to communicate with physicians at the point-of-care, which is especially important due to the declining access to HCPs via sales reps.11

Veradigm Digital Health Media delivers messaging to HCPs directly at the point-of-care via a channel they use every day: their EHRs*. Veradigms ability to reach HCPs at the point of care while they use their EHR means they are accessible far more frequently, and at the right time, than they would be using other promotional options.[1] When advertisers attempted to reach physicians with banner ads, they found that 80% didnt even see the banners because they were blocked by ad-blocking software.9

EHRs are also a preferred means of communication for many HCPs. Research shows that 78% specifically prefer product updates via their EHRs.12

Marketers are increasing spending on a broad range of digital channels, but in the process, they have made a significant shift from personal to nonpersonal promotions.2, 10 Even when using EHR messaging, many biopharma companies use this opportunity simply to repurpose banner ads from other digital channels. However, EHRs provide the opportunity to deliver more personalized, targeted information.12

Recent research shows that many HCPs feel pharma marketers dont understand their needs:13

70% of HCPs surveyed reported feeling that sales reps did not completely understand their needs and expectations 62% reported feeling overwhelmed by the product-related promotional content they received 63% reported the desire for companies to share only relevant content with them

A previous survey yielded similar results:13-15

64% of HCPs surveyed reported getting too much digital content from pharma 65% reported that at least one pharma company had spammed them during the pandemic

Healthcare professionals expect more from pharma brands.8 They are looking for tools to support the use of different drug products, such as access to biopharma if they have questions, or information and resources that can help in their day-to-day practice.12 Research shows that prescribers increasingly rely on their EHRs to include the same tools and capabilities within their workflow that they use to access externally.16

According to one survey, one of marketers most significant opportunities for engaging HCPs is by supporting their communication with patients by making high-quality information and tools for patient education accessible at the point of care while the provider is in their workflow. Providers also have need of:16

According to one survey, HCPs found information on drug affordability programs especially helpful.17

Effective point-of-care EHR marketing can help deliver your branded message throughout the patient encounter. 10 Veradigm Digital Health Media leverages de-identified real-time anonymized data from EHRs to deliver highly targeted brand awareness messaging so your messages can reach the providers who will benefit the most via a channel they use daily.* Awareness messaging is delivered across a broad range of clinical workflow elements used daily in provider/patient consultations, allowing it to be integrated contextually where it can be of the most value, all in a manner compliant with HIPAA and other applicable laws. 10, 12 Veradigm Digital Health Media delivers messages at the point of care alongside multiple EHR platforms and can even help you reach specific providers.*

Biopharma has undergone a digital conversion in the past several years, completely changing its marketing landscape. Digital marketing provides a potential response to a world where traditional marketing strategies are no longer effective, and HCPs are no longer accessible, but it will only be successful if marketers pay attention to what channels and content are effectively reaching and engaging their target audience. Veradigm Digital Health Media can help you accomplish this by reaching providers via a channel they use daily their EHRs* and by leveraging real-time data to allow you to target messaging to the times and contexts where it will provide the greatest value to both providers and their patients.

Contact us to learn more about Veradigm Digital Health Media and how we can help you engage your target audience.

1.Haimowitz I. Measure twice, cut once: AI in biopharma marketing. Deloitte. Updated August 9, 2022. Accessed December 10, 2022, https://www2.deloitte.com/us/en/blog/health-care-blog/2022/measure-twice-cut-once-ai-in-bioparma-marketing.html.

2. Phillips N. Marketing to HCPs in the New World Order. PharmExec.com. Updated May 30, 2020. Accessed December 10, 2022, https://www.pharmexec.com/view/marketing-hcps-new-world-order.

3. Wolf F, Shah S, Meier C, Schulze U. What Doctors Want and What This Means for Biopharma Now. BCG. Updated July 27, 2020. Accessed February 22, 2022, https://www.bcg.com/publications/2020/what-doctors-want-and-what-this-means-for-the-biopharma-industry.

4.Kudumala A, Konersmann T, Israel A, Miranda W. Biopharma digital transformation: Gain an edge with leapfrog digital innovation. Deloitte Insights. Updated December 8, 2021. Accessed December 10, 2022, https://www2.deloitte.com/us/en/insights/industry/life-sciences/biopharma-digital-transformation.html.

5. Droesch B. US Healthcare and Pharma Digital Ad Spending 2020. Insider Intelligence eMarketer. Updated September 30, 2020. Accessed December 10, 2022, https://www.insiderintelligence.com/content/us-healthcare-pharma-digital-ad-spending-2020.

6. Miller M, Ramamurthy S. Ho AI Can Help Drive Biopharma Marketing ROI. The Wall Street Journal. Updated March 23, 2021. Accessed December 10, 2022, https://deloitte.wsj.com/articles/how-ai-can-help-drive-biopharma-marketing-roi-01616526137.

7. Benes R. Marketers Waste About One-Fourth of Their Budgets. Insider Intelligence eMarketer. Updated March 23, 2018. Accessed December 10, 2022, https://www.insiderintelligence.com/content/marketers-waste-about-one-fourth-of-their-budgets.

8. Jain M. Seven Trends Affecting Direct-to-Physician Pharma Marketing. Healthgrades. Updated September 6, 2022. Accessed October 14, 2022, https://b2b.healthgrades.com/insights/blog/seven-trends-affecting-direct-to-physician-pharma-marketing/.

9. Veradigm. Messaging the right HCP at the right time via their electronic health record (EHR). BioPharma Dive. Updated August 15, 2022. Accessed December 10, 2022, https://www.biopharmadive.com/spons/messaging-the-right-hcp-at-the-right-time-via-their-electronic-health-recor/629002/.

10. Warren AT. Why You Multichannel Marketing Mix Should Include EHR Point-of-Service Marketing Partner Content MM + M. Foru Mask. Updated July 30, 2021. Accessed February 22, 2022, https://forumask.net/why-your-multichannel-marketing-mix-should-include-ehr-point-of-service-marketing-partner-content-mm-m/.

11. Sporrer L, Bogus S. Electronic Health Records and Pharmaceutical Advertising. CMI Media Group. Updated February 23, 2021. Accessed February 23, 2022, https://cmimediagroup.com/resources/electronic-health-records-and-pharmaceutical-advertising/.

12. Reifsnyder C. Highlight the Value of Point-of-Care Messaging. Veradigm. Updated March 24, 2022. Accessed December 11, 2022, https://veradigm.com/veradigm-news/value-of-point-of-care-messaging/.

13. Adams B. The drive to digital in pharma marketing is overwhelming doctors. Solution? Train digitally savvy reps. Fierce Pharma. Updated January 10, 2022. Accessed October 13, 2022, https://www.fiercepharma.com/marketing/drive-to-digital-pharma-marketing-overwhelming-doctors-as-industry-must-train-up.

14. Missakian N. How can pharma avoid HCP promo fatigue? With synchronized campaigns and storytelling. Fierce Pharma. Updated February 16, 2022. Accessed October 14, 2022, https://www.fiercepharma.com/marketing/how-can-pharma-avoid-spamming-hcps-synchronized-campaigns-and-storytelling-marketing.

15. Missakian N. Dont spam us, healthcare professionals plea, as they seek quality over quantity from pharma marketers. Fierce Pharma. Updated January 4, 2022. Accessed October 15, 2022, https://www.fiercepharma.com/marketing/hcps-want-less-clutter-more-relevance-from-pharma-marketers-survey-shows.

16. Heinold M. What Prescribers Really Want. PM360. Updated February 9, 2015. Accessed December 12, 2022, https://www.pm360online.com/what-prescribers-really-want/.

17. Pharma Companies Have Improved How They Engage with Healthcare Providers During COVID-19, Finds New Research from Accenture. Accenture. Updated August 10, 2020. Accessed December 12, 2022, https://newsroom.accenture.com/news/pharma-companies-have-improved-how-they-engage-with-healthcare-providers-during-covid-19-finds-new-research-from-accenture.htm.

* Veradigm Digital Health Media services operate in a manner that is compliance with HIPAA and other applicable laws. In addition, the EHR displays advertisements in an iframe window adjacent to the EHR workflow that is separate and distinguishable from the clinical and practice management workflow within the EHR. No biopharma or device advertisements appear during the prescribing workflow.

Link:
Reshaping biopharma marketing with point-of-care messaging - MM+M Online

State Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington Washington D.C. West Virginia Wisconsin Wyoming Puerto Rico US Virgin Islands Armed Forces Americas Armed Forces Pacific Armed Forces Europe Northern Mariana Islands Marshall Islands American Samoa Federated States of Micronesia Guam Palau Alberta, Canada British Columbia, Canada Manitoba, Canada New Brunswick, Canada Newfoundland, Canada Nova Scotia, Canada Northwest Territories, Canada Nunavut, Canada Ontario, Canada Prince Edward Island, Canada Quebec, Canada Saskatchewan, Canada Yukon Territory, Canada

Zip Code

Country United States of America US Virgin Islands United States Minor Outlying Islands Canada Mexico, United Mexican States Bahamas, Commonwealth of the Cuba, Republic of Dominican Republic Haiti, Republic of Jamaica Afghanistan Albania, People's Socialist Republic of Algeria, People's Democratic Republic of American Samoa Andorra, Principality of Angola, Republic of Anguilla Antarctica (the territory South of 60 deg S) Antigua and Barbuda Argentina, Argentine Republic Armenia Aruba Australia, Commonwealth of Austria, Republic of Azerbaijan, Republic of Bahrain, Kingdom of Bangladesh, People's Republic of Barbados Belarus Belgium, Kingdom of Belize Benin, People's Republic of Bermuda Bhutan, Kingdom of Bolivia, Republic of Bosnia and Herzegovina Botswana, Republic of Bouvet Island (Bouvetoya) Brazil, Federative Republic of British Indian Ocean Territory (Chagos Archipelago) British Virgin Islands Brunei Darussalam Bulgaria, People's Republic of Burkina Faso Burundi, Republic of Cambodia, Kingdom of Cameroon, United Republic of Cape Verde, Republic of Cayman Islands Central African Republic Chad, Republic of Chile, Republic of China, People's Republic of Christmas Island Cocos (Keeling) Islands Colombia, Republic of Comoros, Union of the Congo, Democratic Republic of Congo, People's Republic of Cook Islands Costa Rica, Republic of Cote D'Ivoire, Ivory Coast, Republic of the Cyprus, Republic of Czech Republic Denmark, Kingdom of Djibouti, Republic of Dominica, Commonwealth of Ecuador, Republic of Egypt, Arab Republic of El Salvador, Republic of Equatorial Guinea, Republic of Eritrea Estonia Ethiopia Faeroe Islands Falkland Islands (Malvinas) Fiji, Republic of the Fiji Islands Finland, Republic of France, French Republic French Guiana French Polynesia French Southern Territories Gabon, Gabonese Republic Gambia, Republic of the Georgia Germany Ghana, Republic of Gibraltar Greece, Hellenic Republic Greenland Grenada Guadaloupe Guam Guatemala, Republic of Guinea, Revolutionary People's Rep'c of Guinea-Bissau, Republic of Guyana, Republic of Heard and McDonald Islands Holy See (Vatican City State) Honduras, Republic of Hong Kong, Special Administrative Region of China Hrvatska (Croatia) Hungary, Hungarian People's Republic Iceland, Republic of India, Republic of Indonesia, Republic of Iran, Islamic Republic of Iraq, Republic of Ireland Israel, State of Italy, Italian Republic Japan Jordan, Hashemite Kingdom of Kazakhstan, Republic of Kenya, Republic of Kiribati, Republic of Korea, Democratic People's Republic of Korea, Republic of Kuwait, State of Kyrgyz Republic Lao People's Democratic Republic Latvia Lebanon, Lebanese Republic Lesotho, Kingdom of Liberia, Republic of Libyan Arab Jamahiriya Liechtenstein, Principality of Lithuania Luxembourg, Grand Duchy of Macao, Special Administrative Region of China Macedonia, the former Yugoslav Republic of Madagascar, Republic of Malawi, Republic of Malaysia Maldives, Republic of Mali, Republic of Malta, Republic of Marshall Islands Martinique Mauritania, Islamic Republic of Mauritius Mayotte Micronesia, Federated States of Moldova, Republic of Monaco, Principality of Mongolia, Mongolian People's Republic Montserrat Morocco, Kingdom of Mozambique, People's Republic of Myanmar Namibia Nauru, Republic of Nepal, Kingdom of Netherlands Antilles Netherlands, Kingdom of the New Caledonia New Zealand Nicaragua, Republic of Niger, Republic of the Nigeria, Federal Republic of Niue, Republic of Norfolk Island Northern Mariana Islands Norway, Kingdom of Oman, Sultanate of Pakistan, Islamic Republic of Palau Palestinian Territory, Occupied Panama, Republic of Papua New Guinea Paraguay, Republic of Peru, Republic of Philippines, Republic of the Pitcairn Island Poland, Polish People's Republic Portugal, Portuguese Republic Puerto Rico Qatar, State of Reunion Romania, Socialist Republic of Russian Federation Rwanda, Rwandese Republic Samoa, Independent State of San Marino, Republic of Sao Tome and Principe, Democratic Republic of Saudi Arabia, Kingdom of Senegal, Republic of Serbia and Montenegro Seychelles, Republic of Sierra Leone, Republic of Singapore, Republic of Slovakia (Slovak Republic) Slovenia Solomon Islands Somalia, Somali Republic South Africa, Republic of South Georgia and the South Sandwich Islands Spain, Spanish State Sri Lanka, Democratic Socialist Republic of St. Helena St. Kitts and Nevis St. Lucia St. Pierre and Miquelon St. Vincent and the Grenadines Sudan, Democratic Republic of the Suriname, Republic of Svalbard & Jan Mayen Islands Swaziland, Kingdom of Sweden, Kingdom of Switzerland, Swiss Confederation Syrian Arab Republic Taiwan, Province of China Tajikistan Tanzania, United Republic of Thailand, Kingdom of Timor-Leste, Democratic Republic of Togo, Togolese Republic Tokelau (Tokelau Islands) Tonga, Kingdom of Trinidad and Tobago, Republic of Tunisia, Republic of Turkey, Republic of Turkmenistan Turks and Caicos Islands Tuvalu Uganda, Republic of Ukraine United Arab Emirates United Kingdom of Great Britain & N. Ireland Uruguay, Eastern Republic of Uzbekistan Vanuatu Venezuela, Bolivarian Republic of Viet Nam, Socialist Republic of Wallis and Futuna Islands Western Sahara Yemen Zambia, Republic of Zimbabwe

Originally posted here:
The Truth About Gigs, Gs and Other Internet Marketing Jargon - Forest Grove News times